73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and
Study: B cells promote liver cancer with dangerous dual strategy

Study: B cells promote liver cancer with dangerous dual strategy

byGerman Cancer Research CenterGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.04.037Inflammatory fatty liver disease (NASH, non alcoholic steatohepa

Study: B cells promote liver cancer with dangerous dual strategy

byGerman Cancer Research CenterGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.04.037Inflammatory fatty liver disease (NASH, non alcoholic steatohepa
New tools used to identify childhood cancer genes

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene
Researchers set new bases to develop therapies against colorectal cancer

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese
New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

byAmerican Cancer SocietyNew ACS Report. Credit: American Cancer SocietyIn a new report, American Cancer Society (ACS) researchers discovered both favorable and unfavorable changes in major canc

New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

byAmerican Cancer SocietyNew ACS Report. Credit: American Cancer SocietyIn a new report, American Cancer Society (ACS) researchers discovered both favorable and unfavorable changes in major canc
Avoid food poisoning this holiday season

Avoid food poisoning this holiday season

by Dennis Thompson and Carole Tanzer Miller sThe last thing a holiday host wants is to have guests get food poisoning from the feast they've set.That's whyfood safetyis particularl

Avoid food poisoning this holiday season

by Dennis Thompson and Carole Tanzer Miller sThe last thing a holiday host wants is to have guests get food poisoning from the feast they've set.That's whyfood safetyis particularl
Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

by Kindai UniversityThe concentration of soluble PD-L1m PD-1, CTLA4 in plasma were highly correlated with the expression of genes associated with exhaustion in the peripheral CD8+T cells. R valu

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

by Kindai UniversityThe concentration of soluble PD-L1m PD-1, CTLA4 in plasma were highly correlated with the expression of genes associated with exhaustion in the peripheral CD8+T cells. R valu
Experts urge Europe to start planning for lung cancer screening

Experts urge Europe to start planning for lung cancer screening

by University of LiverpoolLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaLeading lung cancer specialists are urging EU countries to take action to initiate life-sa

Experts urge Europe to start planning for lung cancer screening

by University of LiverpoolLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaLeading lung cancer specialists are urging EU countries to take action to initiate life-sa
Study identifies new potential treatment option for triple negative breast cancer

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro
Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre
Editorial: Functional information offers individualized adaptive cancer therapies

Editorial: Functional information offers individualized adaptive cancer therapies

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAn editorial waspublishedin the journalOncoscienceon July 19, 2024, titled "Functional information offers individual

Editorial: Functional information offers individualized adaptive cancer therapies

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAn editorial waspublishedin the journalOncoscienceon July 19, 2024, titled "Functional information offers individual